NCT02188095

Brief Summary

Clinical and radiological 10 year results of Excia T® Hip Stem

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2014

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2014

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 11, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

September 3, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 6, 2015

Completed
10.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 7, 2025

Completed
Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

June 26, 2014

Last Update Submit

February 27, 2026

Conditions

Hip Arthritis

Outcome Measures

Primary Outcomes (1)

  • Survival Rate of the Implant

    Kaplan-Meier Survival Rate up to 10 years

    10 years

Secondary Outcomes (6)

  • Hip disability and Osteoarthritis Outcome Score (HOOS)

    preoperatively, intraoperatively + discharge, after 3 and 12 months 3, 5 and 10 years

  • Change of functional outcome over follow-up period (Harris Hip Score (HHS))

    at discharge, after 3 and 12 months 3, 5 and 10 years

  • Pain Assessment

    at 6 examinations during follow-up (discharge, after 3 and 12 months and 3, 5, and 10 years)

  • Shaftposition ap and lateral

    10 years

  • Stress Shielding

    10 years

  • +1 more secondary outcomes

Study Arms (1)

Excia T®

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

primary care clinic

You may qualify if:

  • Patient gave written informed consent
  • age ≥ 18 years

You may not qualify if:

  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Vulpius Klinik

Bad Rappenau, 74906, Germany

Location

Diakonie Klinikum Stuttgart

Stuttgart, 70176, Germany

Location

Study Officials

  • Peter Aldinger, Prof. Dr.

    Diakonie-Klinikum Stuttgart

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2014

First Posted

July 11, 2014

Study Start

September 3, 2014

Primary Completion

October 6, 2015

Study Completion

November 7, 2025

Last Updated

March 2, 2026

Record last verified: 2026-02

Locations

DE(2)